Mon. 4 Mar 2024, 7:33am ET
Benzinga
News
• Positive data following completion of second cohort of Phase 1 trial of Decoy 20 leads independent Safety Review Committee to recommend initiating multi-dosing cohort
• Single dose cohort data expected to be published at a scientific conference in 2024